| |
| |
|
| Insider
Information: |
Riggs Rory B |
| Relationship: |
Chief Executive Office... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
3,819,637 |
|
|
Indirect Shares
|
745,498 |
|
|
| Direct
Value |
$42,870,305 |
|
|
|
Indirect Value
|
$3,846,662 |
|
|
| Total
Shares |
4,565,135 |
|
|
| Total
Value |
$46,716,967 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
30
|
|
Stock
price went up :
|
1
|
12
|
| Stock
price went down : |
2
|
18
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -14.7%
|
-179.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fibrogen Inc |
FGEN |
Director |
2021-05-26 |
395,750 |
2021-05-26 |
605,713 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
Director |
2024-02-20 |
320,099 |
2024-02-20 |
100,187 |
Premium* |
|
|
Cibus Inc |
CBUS |
Chief Executive Office... |
2023-12-29 |
3,103,788 |
2023-12-29 |
39,598 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2020-10-20 |
4 |
S |
$42.00 |
$19,454,400 |
D/D |
(463,200) |
0 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-03-21 |
4 |
S |
$39.05 |
$1,556,846 |
I/I |
(39,867) |
0 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-05-22 |
4 |
S |
$32.82 |
$57,435,000 |
D/D |
(1,750,000) |
6,762 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,747 |
14,509 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2020-06-18 |
4 |
B |
$28.00 |
$420,000 |
I/I |
15,000 |
15,000 |
2.1 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-01-04 |
4 |
S |
$27.55 |
$983,504 |
D/D |
(35,702) |
20,099 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-01-03 |
4 |
S |
$27.79 |
$5,532,276 |
D/D |
(199,098) |
55,801 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-03-18 |
4 |
S |
$39.38 |
$5,110,675 |
I/I |
(129,222) |
85,187 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2002-12-12 |
4 |
S |
$41.98 |
$1,679,684 |
D/D |
(40,010) |
96,712 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-12-09 |
4 |
S |
$42.07 |
$840,939 |
D/D |
(19,990) |
136,722 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-03-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,836,488) |
141,368 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-11-17 |
4 |
S |
$42.33 |
$5,079,924 |
D/D |
(120,000) |
156,712 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-01-02 |
4 |
S |
$28.52 |
$6,707,081 |
D/D |
(235,200) |
254,899 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-09-15 |
4 |
S |
$42.21 |
$2,195,960 |
D/D |
(52,025) |
276,712 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
320,099 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-09-14 |
4 |
S |
$42.41 |
$2,034,428 |
D/D |
(47,975) |
328,737 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2014-11-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
372,014 |
|
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-08-09 |
4 |
S |
$43.73 |
$1,967,823 |
D/D |
(45,000) |
376,712 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-03-13 |
4 |
S |
$53.07 |
$671,743 |
D/D |
(12,402) |
379,200 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-09-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,250 |
381,650 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
382,900 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
386,350 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
391,050 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-03-12 |
4 |
S |
$54.98 |
$1,082,721 |
D/D |
(19,693) |
391,602 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
395,750 |
0 |
- |
|
73 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
